Adicet Bio, Inc.
ACET
$6.47
-$0.26-3.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 34.34% | 28.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.07% | -13.71% | |||
| Operating Income | -14.07% | 13.71% | |||
| Income Before Tax | -13.63% | 13.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.63% | 13.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.63% | 13.97% | |||
| EBIT | -14.07% | 13.71% | |||
| EBITDA | -15.29% | 14.18% | |||
| EPS Basic | 37.60% | 13.97% | |||
| Normalized Basic EPS | 37.60% | 13.97% | |||
| EPS Diluted | 37.60% | 13.97% | |||
| Normalized Diluted EPS | 37.60% | 13.97% | |||
| Average Basic Shares Outstanding | 82.10% | 0.00% | |||
| Average Diluted Shares Outstanding | 82.10% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||